1-2 of 2
Alex Iwamoto
Close
Sort by
Journal Articles

Allogeneic T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation without Causing Graft-Versus-Host Disease

Jennifer N Brudno, MD, Robert Somerville, Victoria Shi, Jeremy J. Rose, BA, David C. Halverson, MD, Daniel H. Fowler, MD, Dennis D. Hickstein, MD, Juan C. Gea-Banacloche, MD, Steven Z. Pavletic, Andre Goy, MD, Tangying L Lu, Steven Feldman, Alex Iwamoto, Roger Kurlander, Irina Maric, Brenna Hansen, Jennifer S. Wilder, RN, Bazetta Blacklock-Shuver, Frances T. Hakim, Steven A. Rosenberg, MD PhD, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2015) 126 (23): 99.
https://doi.org/10.1182/blood.V126.23.99.99
Published: 2015
Journal Articles

Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma

James N Kochenderfer, MD, Robert Somerville, PhD, Lily Lu, PhD, Alex Iwamoto, B.S., James C Yang, MD, Christopher Klebanoff, MD, Udai Kammula, MD, Richard M Sherry, MD, Shi Victoria, M.S., Constance Yuan, MD PhD, Steven Feldman, PhD, Tatyana Feldman, MD, Andre Goy, MD MS, Kathleen E Morton, RN, Mary Ann Toomey, RN, Steven A. Rosenberg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 550.
https://doi.org/10.1182/blood.V124.21.550.550
Published: 2014